These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7895225)

  • 1. Structural and functional-group tuning in the design of neuraminidase inhibitors.
    Sabesan S; Neira S; Wasserman Z
    Carbohydr Res; 1995 Feb; 267(2):239-61. PubMed ID: 7895225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis.
    Taylor NR; von Itzstein M
    J Med Chem; 1994 Mar; 37(5):616-24. PubMed ID: 8126701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H; Hinou H; Nishimura S
    Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding viral neuraminidase inhibition by substituted difluorosialic acids.
    Weck S; Robinson K; Smith MR; Withers SG
    Chem Commun (Camb); 2015 Feb; 51(14):2933-5. PubMed ID: 25587931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Sialosides Terminated with 8-N-Substituted Sialic Acid as Selective Substrates for Sialidases from Bacteria and Influenza Viruses.
    Mishra B; Yuan Y; Yu H; Kang H; Gao J; Daniels R; Chen X
    Angew Chem Int Ed Engl; 2024 Jul; 63(29):e202403133. PubMed ID: 38713874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping.
    Brouillette WJ; Atigadda VR; Luo M; Air GM; Babu YS; Bantia S
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1901-6. PubMed ID: 10450950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of carbohydrate recognition specificity of human lysozyme revealed by affinity labeling.
    Muraki M; Harata K; Sugita N; Sato K
    Biochemistry; 1996 Oct; 35(42):13562-7. PubMed ID: 8885835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases.
    Carbain B; Martin SR; Collins PJ; Hitchcock PB; Streicher H
    Org Biomol Chem; 2009 Jun; 7(12):2570-5. PubMed ID: 19503932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of aromatic inhibitors of influenza virus neuraminidase.
    Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
    Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of monovalent sialosides by influenza virus H3 hemagglutinin.
    Pritchett TJ; Brossmer R; Rose U; Paulson JC
    Virology; 1987 Oct; 160(2):502-6. PubMed ID: 3660590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic transfer of sialic acids modified at C-5 employing four different sialyltransferases.
    Gross HJ; Brossmer R
    Glycoconj J; 1995 Dec; 12(6):739-46. PubMed ID: 8748149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
    Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two different sialidases, KDN-sialidase and regular sialidase in the starfish Asterina pectinifera.
    Yuziuk JA; Nakagawa H; Hasegawa A; Kiso M; Li SC; Li YT
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):1041-8. PubMed ID: 8645142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative rates of sialylation by recombinant trans-sialidase and inhibitor properties of synthetic oligosaccharides from Trypanosoma cruzi mucins-containing galactofuranose and galactopyranose.
    Agustí R; Giorgi ME; Mendoza VM; Gallo-Rodriguez C; de Lederkremer RM
    Bioorg Med Chem; 2007 Apr; 15(7):2611-6. PubMed ID: 17292612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes.
    Wang T; Wade RC
    J Med Chem; 2001 Mar; 44(6):961-71. PubMed ID: 11300878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of diglucosylamines on two beta-glucosidases.
    Kolarova N; Trgina R; Linek K; Farkas V
    Carbohydr Res; 1995 Aug; 273(1):109-13. PubMed ID: 7553666
    [No Abstract]   [Full Text] [Related]  

  • 18. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
    Meinke S; Schroven A; Thiem J
    Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity of the Trypanosoma cruzi trans-sialidase.
    Vandekerckhove F; Schenkman S; Pontes de Carvalho L; Tomlinson S; Kiso M; Yoshida M; Hasegawa A; Nussenzweig V
    Glycobiology; 1992 Dec; 2(6):541-8. PubMed ID: 1282052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
    Park JY; Jeong HJ; Kim YM; Park SJ; Rho MC; Park KH; Ryu YB; Lee WS
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5602-4. PubMed ID: 21824777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.